Viome

Viome is a biotechnology and healthcare company founded in 2016, headquartered in Bellevue, Washington. The company aims to make illness optional by predicting, preventing, and potentially reversing chronic diseases through a deep understanding of individual biology at the molecular level. Viome utilizes advanced microbiome and human gene expression analysis, employing proprietary technology to provide personalized health insights and nutrition recommendations. Viome offers consumer products that analyze microbiome composition from stool, saliva, and blood samples collected at home. These tests generate individualized recommendations for diet, supplements, and probiotics to enhance digestion, mood, and overall health. Additionally, Viome Life Sciences focuses on discovering predictive biomarkers for chronic diseases and cancer, developing early diagnostic tests, and creating therapeutics to improve health outcomes. The company is expanding its product portfolio to include personalized oral care and skin care products, reflecting its commitment to precision health interventions across various body systems.